Image
|
Figure Caption
Fig. 6 sp5l MO enhances wnt3a loss of function. Embryos were injected with 3.5 mg/ml control morpholino (A,B), 2.5 mg/ml sp5l MO + 1 mg/ml control MO (C,D), 1 mg/ml wnt3a MO +2.5 mg/ml control MO (E,F), or 1 mg/ml wnt3a MO + 2.5 mg/ml sp5l MO (G, H). (A,C,E,G) Live embryos are shown at 48 hpf, anterior to the left. (B,D,F,H) Embryos stained for tbx6 expression at the 10-somite stage and shown in a dorsal view of the tailbud region, anterior to the top.
Figure Data
Acknowledgments
This image is the copyrighted work of the attributed author or publisher, and
ZFIN has permission only to display this image to its users.
Additional permissions should be obtained from the applicable author or publisher of the image.
Full text @ Development